Three single nucleotide polymorphisms of TNFAIP3 gene increase the risk of rheumatoid arthritis

Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic destructive inflammation in synovial joints. To date, many studies explored the associations between tumor necrosis factor alpha inducible protein 3 (TNFAIP3) gene rs6920220, rs2230926, and rs5029937 polymorphisms an...

Full description

Saved in:
Bibliographic Details
Published inOncotarget Vol. 8; no. 13; pp. 20784 - 20793
Main Authors Shen, Nan, Ruan, Yuan, Lu, Yajun, Jiang, Xuefeng, Sun, Huiqing, Gao, Gongming, Nong, Luming, Ren, Kewei
Format Journal Article
LanguageEnglish
Published United States Impact Journals LLC 28.03.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic destructive inflammation in synovial joints. To date, many studies explored the associations between tumor necrosis factor alpha inducible protein 3 (TNFAIP3) gene rs6920220, rs2230926, and rs5029937 polymorphisms and the risk of rheumatoid arthritis (RA), but with contradictory results. We therefore conducted a comprehensive meta-analysis to address the associations. We searched in the databases of PubMed and Embase. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by the Stata 11.0 software. A total of 21 case-control studies for these three single nucleotide polymorphisms (SNPs) were included in this meta-analysis. Meta-analysis indicated that TNFAIP3 gene rs6920220, rs2230926, and rs5029937 polymorphisms were associated with the increased risk of RA. Stratification analysis of ethnicity found that rs6920220 and rs5029937 polymorphisms increased the risk of RA among Caucasians, while rs2230926 polymorphism increased the risk of RA among Asians. In summary, this meta-analysis confirms that TNFAIP3 gene polymorphisms may play important roles in the pathogenesis of RA.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Co-first author
ISSN:1949-2553
1949-2553
DOI:10.18632/oncotarget.15265